Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
S Thakkar, D Sharma, K Kalia, RK Tekade - Acta biomaterialia, 2020 - Elsevier
Recent findings suggest that the cellular and extracellular materials surrounding the
cancerous cells from an atypical tumor microenvironment (TM) play a pivotal role in the …
cancerous cells from an atypical tumor microenvironment (TM) play a pivotal role in the …
Metal nanoparticles: a theranostic nanotool against cancer
Highlights•Metal nanoparticles have been extensively explored for the management of
various disease conditions including cancer.•Metal nanoparticles showed inherent …
various disease conditions including cancer.•Metal nanoparticles showed inherent …
Calcium carbonate nanoparticles as cancer drug delivery system
S Maleki Dizaj, M Barzegar-Jalali… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Calcium carbonate (CaCO3) has broad biomedical utilizations owing to its
availability, low cost, safety, biocompatibility, pH-sensitivity and slow biodegradability …
availability, low cost, safety, biocompatibility, pH-sensitivity and slow biodegradability …
[HTML][HTML] Hard, Soft, and Hard-and-Soft Drug Delivery Carriers Based on CaCO3 and Alginate Biomaterials: Synthesis, Properties, Pharmaceutical Applications
Y Huang, L Cao, BV Parakhonskiy, AG Skirtach - Pharmaceutics, 2022 - mdpi.com
Because free therapeutic drug molecules often have adverse effects on normal tissues,
deliver scanty drug concentrations and exhibit a potentially low efficacy at pathological sites …
deliver scanty drug concentrations and exhibit a potentially low efficacy at pathological sites …
[HTML][HTML] Porous inorganic carriers based on silica, calcium carbonate and calcium phosphate for controlled/modulated drug delivery: Fresh outlook and future …
AD Trofimov, AA Ivanova, MV Zyuzin, AS Timin - Pharmaceutics, 2018 - mdpi.com
Porous inorganic nanostructured materials are widely used nowadays as drug delivery
carriers due to their adventurous features: suitable architecture, large surface area and …
carriers due to their adventurous features: suitable architecture, large surface area and …
[HTML][HTML] Recent advances of calcium carbonate nanoparticles for biomedical applications
P Zhao, Y Tian, J You, X Hu, Y Liu - Bioengineering, 2022 - mdpi.com
Calcium carbonate nanoparticles have been widely used in biomedicine due to their
biocompatibility and biodegradability. Recently, calcium carbonate nanoparticles are largely …
biocompatibility and biodegradability. Recently, calcium carbonate nanoparticles are largely …
Drug nanocrystals: Fabrication methods and promising therapeutic applications
IS Mohammad, H Hu, L Yin, W He - International journal of pharmaceutics, 2019 - Elsevier
The drug nanocrystals (NCs) with unique physicochemical properties are now considered
as a promising drug delivery system for poorly water-soluble drugs. So far> 20 formulations …
as a promising drug delivery system for poorly water-soluble drugs. So far> 20 formulations …
[HTML][HTML] Injected nanocrystals for targeted drug delivery
Nanocrystals are pure drug crystals with sizes in the nanometer range. Due to the
advantages of high drug loading, platform stability, and ease of scaling-up, nanocrystals …
advantages of high drug loading, platform stability, and ease of scaling-up, nanocrystals …
An update on calcium carbonate nanoparticles as cancer drug/gene delivery system
Introduction In recent years, the applications of calcium carbonate (CaCO3) nanoparticles
(NPs) have gained extensive interest as targeted drug/gene delivery systems to cancerous …
(NPs) have gained extensive interest as targeted drug/gene delivery systems to cancerous …
Advances in nano-delivery systems for doxorubicin: an updated insight
U Kanwal, N Irfan Bukhari, M Ovais, N Abass… - Journal of drug …, 2018 - Taylor & Francis
Doxorubicin (DOX) is the most effective chemotherapeutic drug developed against broad
range of cancers such as solid tumours, transplantable leukemias and lymphomas …
range of cancers such as solid tumours, transplantable leukemias and lymphomas …